Detalhe da pesquisa
1.
Cost of post-deployment screening for mental illness in the UK military: findings from a cluster randomised controlled trial.
J Ment Health
; 31(6): 801-808, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30902023
2.
The Economic Cost of Patients With Migraine Headache Referred to Specialist Clinics.
Headache
; 58(2): 287-294, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094342
3.
Reducing outcome measures in mental health: a systematic review of the methods.
J Ment Health
; 25(5): 461-472, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26634396
4.
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison.
Diabetes Res Clin Pract
; 212: 111717, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777128
5.
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design.
Diabetes Ther
; 15(5): 929-1045, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494573
6.
People With Diabetes and Caregivers Prefer Rescue Glucagon Treatment With a Wider Storage Temperature Range and a Nasal Administration, When Efficacy is Similar: A Discrete Choice Experiment in Spain.
J Diabetes Sci Technol
; 17(6): 1623-1633, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533142
7.
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes.
Patient Prefer Adherence
; 17: 793-805, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987498
8.
The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus.
J Med Econ
; 25(1): 393-402, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35105267
9.
Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysis.
J Med Econ
; 25(1): 238-248, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094622
10.
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain.
Diabetes Ther
; 13(4): 775-794, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297026
11.
Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers: Findings from the French cohort.
Ann Endocrinol (Paris)
; 83(1): 16-26, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871601
12.
Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Results from the German Cohort of a Global Survey of People with Type 1 Diabetes or Insulin-Treated Type 2 Diabetes and Caregivers.
Exp Clin Endocrinol Diabetes
; 130(3): 145-155, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368091
13.
Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany.
Diabetes Ther
; 12(11): 2939-2953, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34542865
14.
Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Spanish results of a global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers.
Endocrinol Diabetes Nutr (Engl Ed)
; 68(8): 557-566, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872639
15.
Do welfare benefit reassessments of people with mental health conditions lead to worse mental health? A prospective cohort study.
Int J Soc Psychiatry
; 66(2): 136-149, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782680
16.
An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
Postgrad Med
; 132(8): 727-736, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108957
17.
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy.
Diabetes Ther
; 11(1): 319-330, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760598
18.
Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.
J Diabetes Sci Technol
; 13(5): 910-918, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700165